This inventor holds 5 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignee: Pharmatrophix, Inc.. Active years: 2016-2022.
Location History:
- Menlo Park, CA (US) (2016)
- Reminderville, OH (US) (2018 - 2022)
Company Filing History:
Years Active: 2016-2022
Title: Rajgopal Munigeti: Innovator in Neurotrophin Mimetic Compounds
Introduction
Rajgopal Munigeti is a notable inventor based in Reminderville, OH (US). He has made significant contributions to the field of neurotrophin mimetic compounds, holding a total of 5 patents. His work focuses on the development of crystalline forms of these compounds, which have important therapeutic applications.
Latest Patents
Among his latest patents, Rajgopal has developed crystalline forms of neurotrophin mimetic compounds and their salts. One of his inventions includes crystalline forms of (2S,3S)-2-amino-3-methyl-N-(2-morpholinoethyl)-pentanamide and its salts. This invention not only provides the crystalline forms but also outlines compositions that include these forms and their therapeutic uses. Another patent involves crystalline forms of 2-amino-3-methyl-N-(2-morpholinoethyl)-pentanamide, along with its salts and/or solvates, emphasizing the therapeutic applications of these crystalline forms.
Career Highlights
Rajgopal Munigeti is associated with Pharmatrophix, Inc., where he continues to innovate in the field of neurotrophin mimetics. His work has been instrumental in advancing the understanding and application of these compounds in therapeutic settings.
Collaborations
Rajgopal collaborates with Frank M Longo, a fellow innovator in the field. Their partnership enhances the research and development efforts at Pharmatrophix, Inc.
Conclusion
Rajgopal Munigeti's contributions to the field of neurotrophin mimetic compounds highlight his innovative spirit and dedication to advancing therapeutic solutions. His patents reflect a commitment to improving health outcomes through scientific discovery.